Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
O'Mahony John Mark Insider Profile
4 Followers
O'Mahony John Mark, Chief Manufacturing Officer at Leap Therapeutics, holds 5.00K shares in Leap Therapeutics (Ticker: LPTX).
O'Mahony John Mark has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of O'Mahony John Mark's holdings
Insider Roles
Chief Manufacturing Officer
Roles that O'Mahony John Mark holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by O'Mahony John Mark
O'Mahony John Mark's Trading History
List of latest transactions for each holding click on a transaction to see O'Mahony John Mark's performance on stock
You May Also Like
O'Mahony John Mark insider profile FAQ
What is the percentage of profitable transactions made by O'Mahony John Mark?
The percentage of profitable transactions made by O'Mahony John Mark is ―.
What is the average return per transaction made by O'Mahony John Mark?
The average return per transaction made by O'Mahony John Mark is ―.
What stocks does O'Mahony John Mark hold?
O'Mahony John Mark holds: LPTX stocks.
What was O'Mahony John Mark’s latest transaction?
O'Mahony John Mark latest transaction was an Uninformative Buy of $12.20K.
What was O'Mahony John Mark's most profitable transaction?
O'Mahony John Mark’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is O'Mahony John Mark's role in Leap Therapeutics?
O'Mahony John Mark's role in Leap Therapeutics is Chief Manufacturing Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.